110 related articles for article (PubMed ID: 10071131)
1. Qualitative and quantitative characterization of Fas (APO-1/CD95) on leukemic cells derived from patients with B-cell neoplasms.
Tsuruda K; Yamada Y; Hirakata Y; Sugahara K; Maeda T; Atogami S; Tomonaga M; Kamihira S
Leuk Res; 1999 Feb; 23(2):159-66. PubMed ID: 10071131
[TBL] [Abstract][Full Text] [Related]
2. Quantitative characterization and potential function of membrane Fas/APO-1 (CD95) receptors on leukaemic cells from chronic B and T lymphoid leukaemias.
Kamihira S; Yamada Y; Hirakata Y; Tsuruda K; Sugahara K; Tomonaga M; Maeda T; Tsukasaki K; Atogami S; Kobayashi N
Br J Haematol; 1997 Dec; 99(4):858-65. PubMed ID: 9432034
[TBL] [Abstract][Full Text] [Related]
3. Qualitative and quantitative characterization of Fas (CD95) expression and its role in primary human acute leukemia cells.
Li Q; Tsuruda K; Sugahara K; Dateki N; Ohishi E; Yamada Y; Tomonaga M; Moriuchi H; Tsuji Y; Kamihira S
Leuk Res; 2000 May; 24(5):437-44. PubMed ID: 10785266
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
5. The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis.
Cragg MS; Chan HT; Fox MD; Tutt A; Smith A; Oscier DG; Hamblin TJ; Glennie MJ
Blood; 2002 Nov; 100(9):3068-76. PubMed ID: 12384401
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of CD95 (Fas/Apo-1) on T cells of patients with B-cell chronic lymphocytic leukemia.
Groneberg C; Pickartz T; Binder A; Ringel F; Srock S; Sieber T; Schoeler D; Schriever F
Exp Hematol; 2003 Aug; 31(8):682-5. PubMed ID: 12901972
[TBL] [Abstract][Full Text] [Related]
7. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
Wang D; Freeman GJ; Levine H; Ritz J; Robertson MJ
Br J Haematol; 1997 May; 97(2):409-17. PubMed ID: 9163608
[TBL] [Abstract][Full Text] [Related]
8. CD95 (APO-1/FAS) deficiency in infant acute lymphoblastic leukemia: detection of novel soluble Fas splice variants.
Wood CM; Goodman PA; Vassilev AO; Uckun FM
Eur J Haematol; 2003 Mar; 70(3):156-71. PubMed ID: 12605660
[TBL] [Abstract][Full Text] [Related]
9. Patterns of ganglioside expression in B cell neoplasms.
O'Boyle KP; Freeman K; Kalisiak A; Agregado A; Scheinberg DA
Leuk Lymphoma; 1996 Apr; 21(3-4):255-66. PubMed ID: 8726407
[TBL] [Abstract][Full Text] [Related]
10. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
Robertson MJ; Manley TJ; Pichert G; Cameron C; Cochran KJ; Levine H; Ritz J
Leuk Lymphoma; 1995 Mar; 17(1-2):51-61. PubMed ID: 7539660
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies.
Rozenfeld-Granot G; Toren A; Amariglio N; Brok-Simoni F; Rechavi G
Exp Hematol; 2001 Feb; 29(2):228-33. PubMed ID: 11166462
[TBL] [Abstract][Full Text] [Related]
12. Differential CD95 expression and function in T and B lineage acute lymphoblastic leukemia cells.
Karawajew L; Wuchter C; Ruppert V; Drexler H; Gruss HJ; Dörken B; Ludwig WD
Leukemia; 1997 Aug; 11(8):1245-52. PubMed ID: 9264377
[TBL] [Abstract][Full Text] [Related]
13. Upstream mediators of the Fas apoptotic transduction pathway are defective in B-chronic lymphocytic leukemia.
Roué G; Lancry L; Duquesne F; Salaün V; Troussard X; Sola B
Leuk Res; 2001 Nov; 25(11):967-80. PubMed ID: 11597732
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of chemokine receptors in B cell malignancies.
Dürig J; Schmücker U; Dührsen U
Leukemia; 2001 May; 15(5):752-6. PubMed ID: 11368435
[TBL] [Abstract][Full Text] [Related]
15. Human B-lymphoid cell lines.
Nilsson K
Hum Cell; 1992 Mar; 5(1):25-41. PubMed ID: 1329931
[TBL] [Abstract][Full Text] [Related]
16. Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
Wuchter C; Karawajew L; Ruppert V; Schrappe M; Harbott J; Ratei R; Dörken B; Ludwig WD
Br J Haematol; 2000 Jul; 110(1):154-60. PubMed ID: 10930993
[TBL] [Abstract][Full Text] [Related]
17. Resistance to CD95-mediated apoptosis of CD40-activated chronic lymphocytic leukemia B cells is not related to lack of DISC molecules expression.
de Totero D; Montera M; Rosso O; Clavio M; Balleari E; Foa R; Gobbi M
Hematol J; 2004; 5(2):152-60. PubMed ID: 15048066
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical Detection of Hairy Cell Leukemia in Paraffin Sections: The Role of Pax5 and CD103 Double Staining to Improve Specificity and Sensitivity.
Rozenvald IB; Richardson MD; Brock L; Maiese RL
Arch Pathol Lab Med; 2017 Jun; 141(6):837-840. PubMed ID: 28418282
[TBL] [Abstract][Full Text] [Related]
19. Fas antigen/APO-1 (CD95) expression on myeloma cells.
Shima Y; Nishimoto N; Yoshizaki K; Kishimoto T
Leuk Lymphoma; 1996 Nov; 23(5-6):521-31. PubMed ID: 9031082
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils.
Luttmann W; Opfer A; Dauer E; Foerster M; Matthys H; Eibel H; Schulze-Osthoff K; Kroegel C; Virchow JC
Eur J Immunol; 1998 Jul; 28(7):2057-65. PubMed ID: 9692873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
